BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25985636)

  • 1. [Molecular targeted therapy for leukemic stem cells].
    Kikushige Y
    Nihon Rinsho; 2015 May; 73(5):811-5. PubMed ID: 25985636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].
    Kikushige Y; Miyamoto T; Akashi K
    Rinsho Ketsueki; 2017; 58(10):1838-1843. PubMed ID: 28978822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.
    Kikushige Y; Miyamoto T
    Oncology; 2015; 89 Suppl 1():28-32. PubMed ID: 26551150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.
    Kikushige Y; Miyamoto T
    Int J Hematol; 2013 Dec; 98(6):627-33. PubMed ID: 24046178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells.
    Pelosi E; Castelli G; Testa U
    Blood Cells Mol Dis; 2015 Dec; 55(4):336-46. PubMed ID: 26460257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in leukemic stem cell research for childhood leukemia].
    Eguchi M; Eguchi-Ishimae M; Ishii E
    Rinsho Ketsueki; 2015 Oct; 56(10):1871-81. PubMed ID: 26458424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells?
    García-Ramírez I; Martín-Lorenzo A; González-Herrero I; Rodriguez-Hernández G; Vicente-Dueñas C; Sánchez-García I
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells.
    Kikushige Y; Shima T; Takayanagi S; Urata S; Miyamoto T; Iwasaki H; Takenaka K; Teshima T; Tanaka T; Inagaki Y; Akashi K
    Cell Stem Cell; 2010 Dec; 7(6):708-17. PubMed ID: 21112565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress on targeting leukemia stem cells.
    Ma XY; Wei L; Lei Z; Chen Y; Ding Z; Chen ZS
    Drug Discov Today; 2021 Aug; 26(8):1904-1913. PubMed ID: 34029689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
    Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
    Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New approaches to target leukemia stem cells].
    Takenaka K; Akashi K
    Nihon Rinsho; 2014 Jun; 72(6):1018-25. PubMed ID: 25016798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia.
    Kikushige Y; Akashi K
    Ann N Y Acad Sci; 2012 Aug; 1266():118-23. PubMed ID: 22901263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD123 as a Therapeutic Target Against Malignant Stem Cells.
    Sugita M; Guzman ML
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):553-564. PubMed ID: 32336419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule regulation of normal and leukemic stem cells.
    Fares I; Rivest-Khan L; Cohen S; Sauvageau G
    Curr Opin Hematol; 2015 Jul; 22(4):309-16. PubMed ID: 26049751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in the studies of acute myelogenous leukemia stem cell].
    Cui JW; Zhang XM; Wang GJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):549-52. PubMed ID: 14575558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.
    Yu S; Li F; Xing S; Zhao T; Peng W; Xue HH
    J Biol Chem; 2016 May; 291(21):11148-60. PubMed ID: 27044748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of leukemic stem cells by manipulating the Geminin activity].
    Yasunaga S; Ohno Y; Takihara Y
    Nihon Rinsho; 2015 May; 73(5):800-5. PubMed ID: 25985634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
    Marchand T; Pinho S
    Front Immunol; 2021; 12():775128. PubMed ID: 34721441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis and Isolation of Mouse Leukemic Stem Cells.
    Dong F; Bai H; Ema H
    Methods Mol Biol; 2021; 2185():51-63. PubMed ID: 33165842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How close are we to targeting the leukemia stem cell?
    Pei S; Jordan CT
    Best Pract Res Clin Haematol; 2012 Dec; 25(4):415-8. PubMed ID: 23200537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.